In vivo activation of complement by IgA in a rat model

18Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this study we investigated the capacity of rat IgA to activate complement (C) in vivo rat model. Rat monomeric (m‐), dimeric (d‐) and polymeric (p‐) IgA MoAbs were injected intravenously and assessed for deposition or C3 and C4 on IgA. By ELISA it was shown that both d‐and p‐IgA bound C3 whereas no binding of C3 by m‐IgA was observed. Polymeric IgA was more efficient in binding of C3 as compared with d‐IgA. However, in haemolytic assays no consistent decrease of plasma complement levels was observed except for dimeric IgA which induced a marginal consumption of AP50. When rats were pre‐treated with cobra venom factor (CVF) to deplete C3, no C3 deposition was found on m‐, d‐ or p‐IgA. Neither m‐ nor d‐ or p‐IgA was able to bind C4 in vivo. In agreement with the results described above, large sized polymeric IgA was shown lobe taken up by Kupffer cells (KC) together with C3. No C3 was detected when rats were depleted of C using CVF. Taken together, the experimental data suggest that d‐ and p‐IgA are able to activate C via the alternative pathway in vivo. Copyright © 1992, Wiley Blackwell. All rights reserved

Author supplied keywords

Cite

CITATION STYLE

APA

STAD, R. K., BOGERS, W. M. J. M., THOOMES‐VAN DER SLUYS, M. E., VAN ES, L. A., & DAHA, M. R. (1992). In vivo activation of complement by IgA in a rat model. Clinical & Experimental Immunology, 87(1), 138–143. https://doi.org/10.1111/j.1365-2249.1992.tb06427.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free